Fieldpoint Private Securities’s Ironwood Pharmaceuticals IRWD Stock Holding History

Fieldpoint Private Securities’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3K	Buy	+230	New	+$2.71K	﹤0.01%	1051

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fieldpoint Private Securities's IRWD Position: Q2 2022 in Review

Fieldpoint Private Securities opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2022: 230 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #1051 among its holdings.

239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

Fieldpoint Private Securities held 230 shares of Ironwood Pharmaceuticals worth $3K as of Q2 2022.
Ironwood Pharmaceuticals was a new Fieldpoint Private Securities position in Q2 2022.
Ironwood Pharmaceuticals made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1051 holding.
239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.